A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment

• Hoofdauteurs: Ana Serrano-Martínez (Auteur), Desirée Victoria-Montesinos (Auteur), Ana María García-Muñoz (Auteur), Pilar Hernández-Sánchez (Auteur), Carmen Lucas-Abellán (Auteur), Rebeca González-Louzao (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2023-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

CRLX101 is a cyclodextrin-based nanopharmaceutical designed to improve the delivery and efficacy of the anti-cancer drug camptothecin. Cyclodextrins have unique properties that can enhance drug solubility, stability, and bioavailability, making them an attractive option for drug delivery. The use of...